A growing body of research from Amsterdam UMC and the University of Ghana reveals that type 2 diabetes, long treated as a single disease, operates through two distinct biological mechanisms — one rooted in insulin resistance among heavier patients, another in pancreatic failure among lean ones. Across Africa, where up to 60% of diabetic patients carry normal body weight, millions are receiving medications calibrated for a condition they do not have. This is not merely a clinical oversight; it is a quiet, systemic harm written into the very guidelines meant to heal — one that follows African pa
Study reveals type 2 diabetes in lean Africans requires different treatment approach
Millions of lean African diabetic patients may be receiving ineffective treatment, resulting in higher rates of retinopathy, strokes, and poor blood sugar control.